Skip to main content
. 2017 Feb 15;35(Suppl 1):S57–S63. doi: 10.1097/HJH.0000000000001278

TABLE 3.

Adverse events the first 4 weeks of patiromer treatment

Adverse event Any diuretic (n = 132) No diuretic (n = 111)
Reporting any AE, n (%) 68 (51.5) 46 (41.4)
 Seriousa 3 (2.3) 0
 Leading to discontinuation 9 (6.8) 6 (5.4)
Most common AEs, n (%)b
 Constipation (none severe) 10 (7.6) 16 (14.4)
 Diarrhea (none severe) 7 (5.3) 1 (0.9)

AE, adverse event.

aNone of the serious AEs were considered related to patiromer by the investigators.

bOccurring in 5% or more of patients in either subgroup.